Qube Research & Technologies LTD Guardant Health, Inc. Transaction History

Qube Research & Technologies LTD

$91.4 Billion
Q3 2025

A detailed history of Qube Research & Technologies LTD transactions in Guardant Health, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 570,095 shares of GH stock, worth $53.8 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

570,095

Previous 254,199 124.27%

Holding current value

$53.8 Million

Previous $13.2 Million 169.27%

% of portfolio

0.04%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$40.98 - $67.42 $12.9 Million - $21.3 Million	315,896 Added 124.27%	570,095 $35.6 Million
Q2 2025 Aug 14, 2025	SELL	$37.05 - $52.04 $2.42 Million - $3.39 Million	-65,230 Reduced 20.42%	254,199 $13.2 Million
Q1 2025 May 15, 2025	SELL	$31.77 - $49.94 $2.51 Million - $3.94 Million	-78,958 Reduced 19.82%	319,429 $13.6 Million
Q4 2024 Feb 14, 2025	BUY	$20.2 - $38.11 $6.83 Million - $12.9 Million	338,257 Added 562.54%	398,387 $12.2 Million
Q3 2024 Nov 14, 2024	BUY	$22.3 - $36.29 $1.34 Million - $2.18 Million	60,130 New	60,130 $1.38 Million

Q1 2024 May 14, 2024	BUY	$17.13 - $26.91 $1.36 Million - $2.14 Million	79,536 Added 162.67%	128,430 $2.65 Million
Q4 2023 Feb 13, 2024	BUY	$21.58 - $29.5 $1.06 Million - $1.44 Million	48,894 New	48,894 $1.32 Million
Q1 2023 May 15, 2023	BUY	$22.92 - $33.76 $6.52 Million - $9.61 Million	284,516 Added 76.04%	658,700 $15.4 Million
Q4 2022 Feb 14, 2023	BUY	$25.44 - $59.78 $8.71 Million - $20.5 Million	342,494 Added 1080.76%	374,184 $10.2 Million
Q3 2022 Nov 14, 2022	BUY	$43.66 - $61.0 $349,236 - $487,939	7,999 Added 33.76%	31,690 $1.71 Million
Q2 2022 Aug 15, 2022	BUY	$28.82 - $77.35 $682,774 - $1.83 Million	23,691 New	23,691 $956,000
Q3 2021 Nov 12, 2021	SELL	$98.77 - $132.17 $1.38 Million - $1.85 Million	-13,989 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$109.77 - $165.68 $1.54 Million - $2.32 Million	13,989 New	13,989 $1.74 Million
Q1 2021 May 14, 2021	SELL	$127.04 - $179.1 $6.16 Million - $8.68 Million	-48,475 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$99.96 - $135.93 $4.85 Million - $6.59 Million	48,475 New	48,475 $6.25 Million

Others Institutions Holding GH

# of Institutions

450

Shares Held

125M

Call Options Held

2.18M

Put Options Held

2.69M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $9.65B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Guardant Health, Inc. Transaction History